Key facts
- It has raised $26.9M.
- Notable investors include MedTech Innovator, European Union, Denmark's Export and Investment Fund, Nordic Mentor Network For Entrepreneurship, Nordic Secondary Fund — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for CathVision
- ·The full record, as it builds
Funding rounds
No funding rounds for CathVision are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About CathVision
Developer of an electrophysiology (EP) recording technology designed to diagnose and treat cardiac arrhythmia. The company's systems are artificial intelligence-based, which assist in streaming, analyzing and storing EP signals, enabling physicians to make steady decisions for treating cardiac ablations.
- Sector
- Healthcare
- HQ
- Copenhagen, Denmark
- Founded
- 2010
- Employees
- 41
- Website
- cathvision.com/
- Ownership
- Privately Held (backing)
CathVision doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CathVision shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CathVision in its N-PORT filings yet. We sweep new filings monthly.